NKCC
NKCC (Na-K-Cl cotransporter) is an electrically silent membrane-bound channels that mediates Na and Cl reabsorption. It functions in regulating cell volume and ionic balance.
Products Related to NKCC(6)
- GC16795DCACAS: 2156-56-1Purity: >98.00%
DCA is a metabolic regulator in cancer cells' mitochondria with anticancer activity. DCA inhibits PDHK, resulting in decreased lactic acid in the tumor microenvironment. DCA increases reactive oxygen species (ROS) generation and promotes cancer cell apoptosis. DCA also works as NKCC inhibitor.
- GC36091Furosemide sodiumCAS: 41733-55-5Purity: >99.50%
A loop diuretic inhibitor of Na+/2Cl-/K+ (NKCC) cotransporter
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC12970 | Furosemide | 54-31-9 | >98.00% | |
GABAA receptors antagonist | ||||
| GC15524 | Bumetanide | 28395-03-1 | >99.50% | |
NKCC cotransporter inhibitor | ||||
| GC16795 | DCA | 2156-56-1 | >98.00% | |
DCA is a metabolic regulator in cancer cells' mitochondria with anticancer activity. DCA inhibits PDHK, resulting in decreased lactic acid in the tumor microenvironment. DCA increases reactive oxygen species (ROS) generation and promotes cancer cell apoptosis. DCA also works as NKCC inhibitor. | ||||
| GC36091 | Furosemide sodium | 41733-55-5 | >99.50% | |
A loop diuretic inhibitor of Na+/2Cl-/K+ (NKCC) cotransporter | ||||
| GC38738 | Azosemide | 27589-33-9 | >97.00% | |
Azosemide, a sulfonamide loop diuretic, is a potent NKCC1 inhibitor with IC50s of 0.246??M and 0.197??M for hNKCC1A and NKCC1B, respectively. | ||||
| GC79492 | ML077 | 1135304-61-8 | >98% | |
ML007 is a selective antagonist targeting the neuron-specific potassium-chloride co-transporter 2 ( KCC2 ) with an IC 50 for KCC2 is 537 nM, while its inhibitory activity on KCC1 is extremely weak ( IC 50 > 50 μM). | ||||
